Contact this trialFirst, we need to learn more about you.
Chemotherapy
Neratinib + Chemotherapy for Stomach Cancer
Recruiting1 awardPhase 2
Tampa, Florida
This trial is testing the effects of Neratinib combined with Trastuzumab, Pembrolizumab and FOLFOX chemotherapy in HER2 overexpressing Gastroesophageal cancers. Safety will be monitored.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.